Annual CFI
$0.00
$0.000.00%
31 December 2023
Summary:
Galectin Therapeutics annual cash flow from investing activities is currently $0.00, unchanged on 31 December 2023. During the last 3 years, it has risen by $0.00 (0.00%). GALT annual CFI is now -100.00% below its all-time high of $4.95 million, reached on 31 December 2007.GALT Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
N/A
30 September 2024
Summary:
Galectin Therapeutics quarterly cash flow from investing activities is not available.GALT Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
N/A
30 September 2024
Summary:
Galectin Therapeutics TTM cash flow from investing activities is not available.GALT TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GALT Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | 0.0% | - | - |
| 3 y3 years | 0.0% | - | - |
| 5 y5 years | 0.0% | - | - |
GALT Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time | -100.0% | +100.0% |
Galectin Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | $0.00(0.0%) | - | - |
| Dec 2022 | $0.00(0.0%) | - | - |
| Dec 2021 | $0.00(0.0%) | - | - |
| Dec 2020 | $0.00(0.0%) | - | - |
| Dec 2019 | $0.00(0.0%) | - | - |
| Dec 2018 | $0.00(0.0%) | - | - |
| Dec 2017 | $0.00(0.0%) | - | - |
| Dec 2016 | $0.00(0.0%) | - | - |
| Dec 2015 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(0.0%) |
| June 2015 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2015 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Dec 2014 | -$400.00 K(<-9900.0%) | $0.00(0.0%) | -$400.00 K(0.0%) |
| Sept 2014 | - | $0.00(0.0%) | -$400.00 K(0.0%) |
| June 2014 | - | $0.00(-100.0%) | -$400.00 K(0.0%) |
| Mar 2014 | - | -$400.00 K(<-9900.0%) | -$400.00 K(<-9900.0%) |
| Dec 2013 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(-100.0%) |
| Sept 2013 | - | $0.00(0.0%) | $56.00 K(-12.5%) |
| June 2013 | - | $0.00(0.0%) | $64.00 K(0.0%) |
| Mar 2013 | - | $0.00(-100.0%) | $64.00 K(0.0%) |
| Dec 2012 | $64.00 K(-526.7%) | $56.00 K(+600.0%) | $64.00 K(+2033.3%) |
| Sept 2012 | - | $8000.00(>+9900.0%) | $3000.00(-130.0%) |
| June 2012 | - | $0.00(0.0%) | -$10.00 K(-33.3%) |
| Mar 2012 | - | $0.00(-100.0%) | -$15.00 K(0.0%) |
| Dec 2011 | -$15.00 K(<-9900.0%) | -$5000.00(0.0%) | -$15.00 K(+50.0%) |
| Sept 2011 | - | -$5000.00(0.0%) | -$10.00 K(+100.0%) |
| June 2011 | - | -$5000.00(<-9900.0%) | -$5000.00(<-9900.0%) |
| Mar 2011 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2010 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2010 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2010 | - | $0.00 | $0.00 |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2009 | $0.00(-100.0%) | - | - |
| Dec 2008 | $9000.00(-99.8%) | $3000.00(-40.0%) | $9000.00(-77.5%) |
| Sept 2008 | - | $5000.00(>+9900.0%) | $40.00 K(+17.6%) |
| June 2008 | - | $0.00(-100.0%) | $34.00 K(-261.9%) |
| Mar 2008 | - | $1000.00(-97.1%) | -$21.00 K(-100.4%) |
| Dec 2007 | $4.95 M(-194.5%) | $34.00 K(-3500.0%) | $4.95 M(+2.2%) |
| Sept 2007 | - | -$1000.00(-98.2%) | $4.84 M(+1.7%) |
| June 2007 | - | -$55.00 K(-101.1%) | $4.76 M(-1997.2%) |
| Mar 2007 | - | $4.97 M(-7098.6%) | -$251.00 K(-95.2%) |
| Dec 2006 | -$5.24 M(+4617.1%) | -$71.00 K(-12.3%) | -$5.24 M(+1.6%) |
| Sept 2006 | - | -$81.00 K(-98.4%) | -$5.16 M(+0.9%) |
| June 2006 | - | -$5.07 M(>+9900.0%) | -$5.11 M(+5451.1%) |
| Mar 2006 | - | -$16.00 K(-260.0%) | -$92.00 K(-17.1%) |
| Dec 2005 | -$111.00 K(+60.9%) | $10.00 K(-130.3%) | -$111.00 K(-11.9%) |
| Sept 2005 | - | -$33.00 K(-37.7%) | -$126.00 K(+2.4%) |
| June 2005 | - | -$53.00 K(+51.4%) | -$123.00 K(+60.4%) |
| Mar 2005 | - | -$35.00 K(+600.0%) | -$76.70 K(+11.2%) |
| Dec 2004 | -$69.00 K(-34.3%) | -$5000.00(-83.3%) | -$69.00 K(-15.3%) |
| Sept 2004 | - | -$30.00 K(+347.8%) | -$81.50 K(+19.3%) |
| June 2004 | - | -$6700.00(-75.5%) | -$68.30 K(-21.8%) |
| Mar 2004 | - | -$27.30 K(+56.0%) | -$87.30 K(-16.9%) |
| Dec 2003 | -$105.00 K(-24.1%) | -$17.50 K(+4.2%) | -$105.00 K(-13.2%) |
| Sept 2003 | - | -$16.80 K(-34.6%) | -$121.00 K(+11.2%) |
| June 2003 | - | -$25.70 K(-42.9%) | -$108.80 K(-19.6%) |
| Mar 2003 | - | -$45.00 K(+34.3%) | -$135.40 K(-2.1%) |
| Dec 2002 | -$138.30 K(-19.2%) | -$33.50 K(+628.3%) | -$138.30 K(+32.0%) |
| Sept 2002 | - | -$4600.00(-91.2%) | -$104.80 K(+4.6%) |
| June 2002 | - | -$52.30 K(+9.2%) | -$100.20 K(+109.2%) |
| Mar 2002 | - | -$47.90 K | -$47.90 K |
| Dec 2001 | -$171.10 K | - | - |
FAQ
- What is Galectin Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Galectin Therapeutics?
- What is Galectin Therapeutics annual CFI year-on-year change?
- What is the all time high quarterly CFI for Galectin Therapeutics?
- What is the all time high TTM CFI for Galectin Therapeutics?
What is Galectin Therapeutics annual cash flow from investing activities?
The current annual CFI of GALT is $0.00
What is the all time high annual CFI for Galectin Therapeutics?
Galectin Therapeutics all-time high annual cash flow from investing activities is $4.95 M
What is Galectin Therapeutics annual CFI year-on-year change?
Over the past year, GALT annual cash flow from investing activities has changed by $0.00 (0.00%)
What is the all time high quarterly CFI for Galectin Therapeutics?
Galectin Therapeutics all-time high quarterly cash flow from investing activities is $4.97 M
What is the all time high TTM CFI for Galectin Therapeutics?
Galectin Therapeutics all-time high TTM cash flow from investing activities is $4.95 M